XRP tests the $1.32 support level as ETF demand slows
Key takeaways XRP has declined nearly 7% over seven days after failing to clear resistance at $1.60. Trading volume remains around $3 billion,
Crypto
Economy
Nvidia stock takes a hit as portfolio stocks dive and Reflection AI bid is considered
Nvidia stock has pulled back in the past four consecutive days. It has slumped from the all-time high of $243 to the current
Business
Anthropic’s 14 October Investor Day Nears, but Its…
Anthropic is reportedly preparing to meet prospective IPO investors at its San Francisco headquarters on Wednesday, October 14, bringing the Claude developer closer
Latest News
Nike has a long road ahead to win customers back
When I was a kid, Nike was the pinnacle of cool footwear. Of course, there were other competitive athletic shoe brands like Reebok
Stocks
Amazon plans $7 billion acquisition of Decart, a fast-growing AI startup
Amazon is in talks to acquire Decart, a fast-growing artificial intelligence (AI) company. According to the WSJ, Amazon is planning to buy the
Investing
US diesel is $6.28 a gallon, and the first Russian cargo…
A US import license is not a diesel cargo, and the cargo President Trump named is not a day of American use. The
Crypto
Dogecoin dips by 11% this week as whale balances shrink
Key takeaways Dogecoin traded near $0.085 on Friday after losing more than 11% this week. Two large-wallet cohorts reduced their combined holdings by
Economy
Coherent stock forms bullish pattern as Lumentum projects strong optics demand
Coherent (COHR) stock has wavered since mid-August, in step with the consolidation among leading companies in the artificial intelligence industry. Shares were trading
Business
Blockchain.com Seeks CFTC Approval for U.S. Prediction…
Blockchain.com has applied for two licenses from the U.S. Commodity Futures Trading Commission (CFTC) to offer prediction markets and cryptocurrency derivatives to retail
Latest News
Crumbl store closures reveal a bigger problem
Crumbl faces two massive problems. First, the chain sells a pricey indulgence customers don’t actually need. Second, millions of Americans are taking GLP-1